X-ray diffraction studies reveal the structure of {[(2-CsH5-1,2-C2BloHlo-I-COO)Bu2Sn]20}2, 1, to conform to the common motif found for {[(R'COO)R2Sn]20}2 compounds. The dimer features a central Bu4Sn202 unit (two-fold symmetry) with the two Bu2Sn groups being linked via bridging oxygen atoms, each of which also carries an exocyclic Bu2Sn moiety. The two pairs of exo-and endo-cyclic tin atoms are each linked via an almost symmetrically bridging carboxylate ligand and the two remaining ligands coordinate an exocyclic tin atom only, in the monodentate mode. The in vitro anti-tumour activity of 1, determined against a variety of cell lines, is compared with those of the corresponding 2-methylcarboranylacetate, derivative 2, and with clinically used compounds.
Introduction
The in vitro anti-tumour activity of many compounds of the type {[(R'COO)Bu2Sn]20}2 has been determined [1] [2] [3] [4] . Generally, the compounds are quite active. The synthesis and X-ray crystal structure of the dimeric bis-[(1,7-dicarba-c/oso-dodecaborane-l-carboxylato)-di-n-butyltin] oxide, {[(1,7-C2B10H11-1-COO)Bu2Sn]20}2, has already been reported [5] . Its in vitro anti-tumour activity is less than those of several compounds of the type {[(R'COO)Bu2Sn]20}2, comparable to those of methotrexate and doxorubicin, but greater than those of 5-fluorouracil, cis-platin and carboplatin [5] . As a continuation of studies on organotin carboxylates, the synthesis, spectral characterisation, and in vitro anti-tumour activity of a bis-[(2-phenyl-1,2-carborane-l-carboxylato)di-n-butyltin] oxide, {[(2-C6H5-1,2-C2BloHlo-I-COO)Bu2Sn]20}2 (1) , and of bis[1-(2-methyl-1,2-carboranyl)-l-acetato-di-nbutyltin] oxide, {[(2-CH3-1,2-C2B10H10-1-CH2-COO)Bu2Sn]20}2 (2) , are reported together with the Xray structure of 1.
Results and Discussion

Synthesis
The novel dimeric bis[(2-phenyl-l,2-dicarba-closo-dodecaborane-l-carboxylato)-di-nbutyltin] oxide, compound 1, was obtained from a 1:1 condensation of dibutyltin(IV) oxide with 2-phenyl-1,2-carborane-l-carboxylic acid. Its structure was determined by spectroscopic and X-ray diffraction methods. The 1-(2-methyl-l,2-carboranyl)acetate derivative, 2, was synthesised using an analogous procedure. The (4)' interactions were considered significant, the molecular geometry may be described as being based on a Sn404 ladder, however, the relatively weak nature of these interactions suggests that a better description would be one based on a partially completed ladder. 
A partial crystal structure of 2 was obtained (see Experimental) . The refinement halted at R ca 13 % and hence, the derived parameters are not reliable. The gross structural features were determined unambiguously, however, and showed that the common (i.e. centrosymmetric) motif found for {[(R'COO)R2Sn]20}2 is adopted by 2 [6] . Table 2. Against these cell lines, compounds 1 and 2 are significantly more active than 5-fluorouracil, cis-platin and carboplatin but less active than methotrexate and doxorubicin, whereas the parent carboxylic acid of 1 is inactive. The results for 1 and 2 are similar to those reported earlier for {[(1,7-C2B10H11-1-COO)Bu2Sn]20}2 [5] and show that these carborane derivatives possess medium activity. (2-Methyl-1,2-carboran-l-yl)acetic acid, compound 4, was also prepared following Zakharkin et al. [7b] by the action of equimolar amount of magnesium on 2-methyl-l-chloromethyl-l,2-carborane followed by carboxylation with CO2 of the Grignard reagent obtained, followed by acid hydrolysis.
Compound 1 was synthesised in benzene (150 mL) from di-n-butyltin oxide ( 1  138  164  514  169  220  301  388  2  74  140  283  102  172  182  246  3  56500  1750  45100  42400  58300  >60000 55000  Carboplatin  10500  4500  3500  2400  5500  1800 25000  Cis-platin  1400  920  1550  230  780  1200  3158  5-Fluorouracil  350  720  440  850  31 0  340  5300  Doxorubicin  25  3  8  150  21  55  80  Methotrexate   5  26  7  20  8  6  70 3.
Intensity data for a colourless crystal (0.10 x 0.26 x 0.39 mm) were measured at room temperature on a Rigaku AFC6R diffractometer fitted with MoKo radiation (graphite monochromator, X 0.71073 A) using the e:2e scan technique so that emax was 27.5. No decomposition of the crystal occurred during the data collection and the data set was corrected for Lorentz and polarization effects [8] , and for absorption employing an empirical procedure (range of transmission factors: 0.942 1) [9] . A total of 12166 data (11932 unique) were collected and of these, 5729 that satisfied the > 3.0(/) criterion were used in the subsequent analysis. 3.6. In vitro screening The in vitro tests were performed as described previously [14] .
